257 related articles for article (PubMed ID: 25636780)
1. Enhancement of protoporphyrin IX performance in aqueous solutions for photodynamic therapy.
Homayoni H; Jiang K; Zou X; Hossu M; Rashidi LH; Chen W
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):258-66. PubMed ID: 25636780
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and conjugation of Sr
Homayoni H; Ma L; Zhang J; Sahi SK; Rashidi LH; Bui B; Chen W
Photodiagnosis Photodyn Ther; 2016 Dec; 16():90-99. PubMed ID: 27594671
[TBL] [Abstract][Full Text] [Related]
3. Latex carrier for improving protoporphyrin IX for photodynamic therapy.
Bui B; Liu L; Chen W
Photodiagnosis Photodyn Ther; 2016 Jun; 14():159-65. PubMed ID: 27020668
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular uptake of protoporphyrine IX/linolenic acid-conjugated spherical nanohybrids for photodynamic therapy.
Lee HI; Kim YJ
Colloids Surf B Biointerfaces; 2016 Jun; 142():182-191. PubMed ID: 26954084
[TBL] [Abstract][Full Text] [Related]
5. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy.
Taba F; Onoda A; Hasegawa U; Enoki T; Ooyama Y; Ohshita J; Hayashi T
ChemMedChem; 2018 Jan; 13(1):15-19. PubMed ID: 28961376
[TBL] [Abstract][Full Text] [Related]
7. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study.
Basoglu H; Bilgin MD; Demir MM
Photodiagnosis Photodyn Ther; 2016 Mar; 13():81-90. PubMed ID: 26751701
[TBL] [Abstract][Full Text] [Related]
8. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX.
Ding H; Sumer BD; Kessinger CW; Dong Y; Huang G; Boothman DA; Gao J
J Control Release; 2011 May; 151(3):271-7. PubMed ID: 21232562
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the emission spectra and cytotoxicity of TiO
Vejdani Noghreiyan A; Sazegar MR; Mousavi Shaegh SA; Sazgarnia A
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101770. PubMed ID: 32311544
[TBL] [Abstract][Full Text] [Related]
10. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells.
Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y
J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723
[TBL] [Abstract][Full Text] [Related]
11. Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy.
Wang LY; Shi XY; Yang CS; Huang DM
Nanoscale; 2013 Jan; 5(1):416-21. PubMed ID: 23187860
[TBL] [Abstract][Full Text] [Related]
12. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
13. Physiological considerations acting on triplet oxygen for explicit dosimetry in photodynamic therapy.
Sánchez V; Romero MP; Pratavieira S; Costa C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():298-303. PubMed ID: 28750754
[TBL] [Abstract][Full Text] [Related]
14. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy.
Qian J; Gharibi A; He S
J Biomed Opt; 2009; 14(1):014012. PubMed ID: 19256700
[TBL] [Abstract][Full Text] [Related]
15. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers.
Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV
Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201
[TBL] [Abstract][Full Text] [Related]
16. Carbon dot-protoporphyrin IX conjugates for improved drug delivery and bioimaging.
Aguilar Cosme JR; Bryant HE; Claeyssens F
PLoS One; 2019; 14(7):e0220210. PubMed ID: 31344086
[TBL] [Abstract][Full Text] [Related]
17. Stabilized tetraether lipids based particles guided prophyrins photodynamic therapy.
Mahmoud G; Jedelská J; Omar SM; Strehlow B; Schneider M; Bakowsky U
Drug Deliv; 2018 Nov; 25(1):1526-1536. PubMed ID: 29996694
[TBL] [Abstract][Full Text] [Related]
18. Determination and analysis of singlet oxygen quantum yields of talaporfin sodium, protoporphyrin IX, and lipidated protoporphyrin IX using near-infrared luminescence spectroscopy.
Nishimura T; Hara K; Honda N; Okazaki S; Hazama H; Awazu K
Lasers Med Sci; 2020 Aug; 35(6):1289-1297. PubMed ID: 31853809
[TBL] [Abstract][Full Text] [Related]
19. Correlation of in vitro cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in mitochondria and plasma membrane.
Li B; Shen Y; Lin H; Wilson BC
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104080. PubMed ID: 38583747
[TBL] [Abstract][Full Text] [Related]
20. Dual-photosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy.
Sengar P; Garcia-Tapia K; Chauhan K; Jain A; Juarez-Moreno K; Borbón-Nuñez HA; Tiznado H; Contreras OE; Hirata GA
J Colloid Interface Sci; 2019 Feb; 536():586-597. PubMed ID: 30390584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
